Home › Therapeutic areas › Oncology › Acute Myeloid Leukemia
Acute Myeloid Leukemia (8 companies)
Companies with an active program in Acute Myeloid Leukemia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ACRV | Acrivon Therapeutics | Oncology | 1 | Phase 2 | 5 |
| ALLO | Allogene Therapeutics, Inc. | ImmunologyOncology Rare | 1 | Phase 2 | 12 |
| CGEM | Cullinan Therapeutics, Inc. | ImmunologyOncology | 1 | NDA Submitted | 7 |
| INAB | IN8BIO, INC. | ImmunologyOncology | 1 | Phase 2 | 6 |
| KURA | Kura Oncology, Inc. | MetabolicOncology | 1 | Phase 1 | 9 |
| MRKR | Marker Therapeutics, Inc. | Oncology | 1 | Phase 1 | 4 |
| OMER | OMEROS CORP | HematologyNeurologyOncologyRespiratory Rare | 1 | NDA Submitted | 7 |
| SLS | SELLAS Life Sciences Group, Inc. | Oncology | 2 | Phase 3 | 8 |
No companies match.